SELBORNE
LIVE

Serial Number

77141759

Owner

Selborne Biological Services (Australia), Pty Ltd

Attorney

David J. Langeland

First Use Date

Aug 31, 1988

Filing Date

Mar 27, 2007

Add to watchlist:

No watchlists yet
View on USPTO

SELBORNE Trademark

Serial Number: 77141759 • Registration: 3447685

SELBORNE is a trademark filed by Selborne Biological Services (Australia), Pty Ltd on March 27, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Selborne Biological Services (Australia), Pty Ltd (3 trademarks)

390 Illawarra Road
Longford 7301 , AU

Entity Type: 99

Trademark Details

Filing Date

March 27, 2007

Registration Date

June 17, 2008

First Use Anywhere

August 31, 1988

Published for Opposition

April 1, 2008

Goods & Services

Biological and chemical preparations and reagents for medical and veterinary use, namely, reagents for use in the development of monoclonal antibodies; culture media for medical, veterinary, diagnostic and biopharmaceutical use; biological preparations for medical purposes, namely, use in cell cultures; blood culture media for medical and veterinary use; proteins for medical use in binding and detecting antibodies; sera for medical purposes, namely, use in vaccines, cell and tissue cultures and in growth media supplements; antisera for medical use, namely, antisera for in vivo use; antibodies for therapeutic purposes, namely, use in therapeutic products, and diagnostic applications; blood, namely, blood for medical purposes; blood plasma, namely, blood plasma for pharmaceutical preparations, not as raw materials; blood grouping reagents for medical use; blood protein fractions for medical purposes, namely, use in cell culture products and diagnostic applications; polyclonal preparations, namely, antisera, antiplasma, and polyclonal antibodies, which are not raw materials, for use in preparing active pharmaceutical ingredients; diagnostic preparations, substances, agents and reagents for medical, clinical and pharmaceutical use

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 9, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 9, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 9, 2018 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 9, 2018 APRE
TEAS SECTION 8 & 9 RECEIVED
Nov 1, 2018 E89R
WITHDRAWAL OF ATTORNEY GRANTED
Nov 22, 2016 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Nov 22, 2016 WOAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 10, 2014 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 10, 2014 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 10, 2014 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jan 29, 2014 815F
TEAS SECTION 8 & 15 RECEIVED
Jan 29, 2014 E815
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2008 R.PR
PUBLISHED FOR OPPOSITION
Apr 1, 2008 PUBO
NOTICE OF PUBLICATION
Mar 12, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 26, 2008 PREV
ASSIGNED TO LIE
Feb 26, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 29, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 29, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 29, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 29, 2008 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 11, 2007 GNRN
NON-FINAL ACTION E-MAILED
Jul 11, 2007 GNRT
NON-FINAL ACTION WRITTEN
Jul 11, 2007 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2007 DOCK
NEW APPLICATION ENTERED
Mar 30, 2007 NWAP